ŸÀÌƲÇмú´ëȸ ¾È³»

ÀÏ ½Ã
2020³â 7¿ù 17ÀÏ(±Ý) - 18ÀÏ(Åä)
Àå ¼Ò
±¤ÁÖ ¶ó¸¶´ÙÇöóÀÚÈ£ÅÚ
»çÀüµî·Ï ±â°£
2020³â 2¿ù 17ÀÏ(¿ù) ~ 7¿ù 6ÀÏ(¿ù)±îÁö
µî ·Ï ºñ
»çÀüµî·Ï - Àü¹®ÀÇ 50,000¿ø, Àü°øÀÇ/°£È£»ç ¹× ±âŸ 30,000¿ø
ÇöÀåµî·Ï - Àü¹®ÀÇ 60,000¿ø, Àü°øÀÇ/°£È£»ç ¹× ±âŸ 40,000¿ø
°èÁ¹øÈ£
KEBÇϳªÀºÇà 501-910052-96405 (¿¹±ÝÁÖ : ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ)

ŸÀÌƲÇÁ·Î±×·¥



7¿ù 17ÀÏ(±Ý¿äÀÏ)
12:30 - 13:30 ÆòÀÇ¿øȸ
13:30 - 13:50 µî·Ï
13:50 - 14:00 ȸÀå´Ô, ÀÌ»çÀå´Ô Àλç
14:00 - 16:00 Scientific Session I : Biologic Therapy for Pediatric Cancer
14:00 - 14:30 Immune checkpoint blockade therapy in children ÇÑÁ¤¿ì (¿¬¼¼ÀÇ´ë)
14:30 - 15:00 TKI in therapy in solid tumor ÃÖÁ¤À± (¼­¿ïÀÇ´ë)
15:00 - 15:40 TKI therapy in hematologic malignancy Michel Zwaan (Princess Maxima Center for Pediatric Oncology, Germany)
15:40 - 16:00 Coffee Break
16:00 - 17:10 Scientific Session II : Veno-Occlusive Disease (VOD)
16:00 - 16:30 Chemotherapy induced VOD ¾çÀ¯Áø (ºÎ»êÀÇ´ë)
16:30 - 17:10 VOD after HSCT Krzysztof Kalwak (Wroclaw Medical University, Poland)
17:10 - 18:00 Case Discussion Session °í°æ³² (¿ï»êÀÇ´ë)


7¿ù 18ÀÏ(Åä¿äÀÏ)
09:00 - 10:00 K-PHOG Session / °£È£»ç Session ¡¡
10:00 - 10:20 Coffee Break
10:20 - 11:00 Special Lecture
10:20 - 11:00 Medical system for pediatric cancer in Netherlands Michel Zwaan (Princess Maxima Center for Pediatric Oncology, Germany)
11:00 - 12:00 Scientific Session III : Cancer Predisposing Syndrome
11:00 - 11:30 Overview of cancer predisposing syndrome ÀÌÁö¿ø (¼º±Õ°üÀÇ´ë)
11:30 - 12:00 Multidisciplinary approach for NF1 ±èÇý¸® (¿ï»êÀÇ´ë)
12:00 Æóȸ